The Safety Rates Drug Report

Member Login
2004.Q1    2004.Q2    2004.Q3    2004.Q4    2005.Q1    2005.Q2    2005.Q3    2005.Q4    2006.Q1    2006.Q2    2006.Q3    2006.Q4    2007.Q1    2007.Q2    2007.Q3    2007.Q4    2008.Q1    2008.Q2    2008.Q3    2008.Q4    2009.Q1    2009.Q2    2009.Q3    2009.Q4    2010.Q1    2010.Q2    2010.Q3    2010.Q4    2011.Q1    2011.Q2    2011.Q3    2011.Q4    2012.Q1    2012.Q2    2012.Q3    2012.Q4    2013.Q1    2013.Q2    2013.Q3    2013.Q4    2014.Q1    2014.Q2    2014.Q3    2014.Q4    2015.Q1    2015.Q2    2015.Q3    2015.Q4    2016.Q1    2016.Q2    2016.Q3   

Drug     Injury     Quarter    

Person who experienced the adverse event (patient)

Event ID CASEID CASEVERSION I F COD EVENT DT MFR DT INIT FDA DT FDA DT REPT COD AUTH NUM MFR NUM MFR SNDR LIT REF AGE AGE COD AGE GRP GNDR COD E SUB WT WT COD REPT DT TO MFR OCCP COD REPORTER COUNTRY OCCR COUNTRY
123648163 12364816 3 F 2010 20160922 20160513 20160927 EXP US-B.I. PHARMACEUTICALS,INC./RIDGEFIELD-2016-BI-29301BP BOEHRINGER INGELHEIM 70.89 YR F Y 136.98000 KG 20160927 OT US US

Drug(s) used by person

Event ID CASEID DRUG SEQ ROLE COD DRUGNAME PROD AI VAL VBM ROUTE DOSE VBM CUM DOSE CHR CUM DOSE UNIT DECHAL RECHAL LOT NUM EXP DT NDA NUM DOSE AMT DOSE UNIT DOSE FORM DOSE FREQ
123648163 12364816 1 PS ATROVENT IPRATROPIUM BROMIDE 1 Respiratory (inhalation) 170 MCG Y 10005717 21527 34 UG NEBULISER LIQUID
123648163 12364816 2 SS ATROVENT IPRATROPIUM BROMIDE 1 Respiratory (inhalation) 8 ANZ Y 10005717 21527 NEBULISER LIQUID QID
123648163 12364816 3 SS ATROVENT IPRATROPIUM BROMIDE 1 Y 10005717 21527
123648163 12364816 4 C CRESTOR ROSUVASTATIN CALCIUM 1 Oral 20 MG 0 20 MG TABLET QD
123648163 12364816 5 C LISINOPRIL. LISINOPRIL 1 Oral 10 MG 0 10 MG TABLET QD
123648163 12364816 6 C PREVICID 2 Oral 30 MG 0 30 MG CAPSULE QD
123648163 12364816 7 C METFORMIN METFORMIN HYDROCHLORIDE 1 Oral 2000 MG 0 1000 MG TABLET BID
123648163 12364816 8 C NOVOLOG INSULIN ASPART 1 Subcutaneous 66 U 0 22 IU
123648163 12364816 9 C LANTUS INSULIN GLARGINE 1 Subcutaneous 35 U 0 35 IU
123648163 12364816 10 C LEVOTHYROXINE. LEVOTHYROXINE 1 Oral 150 MG 0 150 MG TABLET QD
123648163 12364816 11 C MAGNESIUM MAGNESIUM 1 Oral 400 MG 0 400 MG TABLET QD
123648163 12364816 12 C CALCIUM PLUS 2 Oral 1 ANZ 0 TABLET QD
123648163 12364816 13 C BABY ASPIRIN ASPIRIN 1 Oral 1 ANZ 0 TABLET QD
123648163 12364816 14 C Vitamin D 3 2 Oral 1000 U 0 1000 IU CAPSULE QD
123648163 12364816 15 C VITAMIN E .ALPHA.-TOCOPHEROL 1 Oral 0 QD
123648163 12364816 16 C BIOTIN BIOTIN 1 Oral 10000 MCG 0 10000 UG TABLET QD
123648163 12364816 17 C CHLORPHENIRAMINE MALEATE. CHLORPHENIRAMINE MALEATE 1 Oral 4 MG 0 4 MG TABLET QD
123648163 12364816 18 C ASPIRIN. ASPIRIN 1 Oral 81 MG 0 81 MG TABLET QD
123648163 12364816 19 C CALCIUM + VITAMIN D3 CALCIUMCHOLECALCIFEROL 1 Oral 1 ANZ 0 TABLET QD

Indications of drugs used

Event ID CASEID INDI DRUG SEQ INDI PT
123648163 12364816 1 Asthma
123648163 12364816 2 Chronic obstructive pulmonary disease
123648163 12364816 3 Dyspnoea
123648163 12364816 4 Blood cholesterol increased
123648163 12364816 5 Hypertension
123648163 12364816 6 Gastrooesophageal reflux disease
123648163 12364816 7 Diabetes mellitus
123648163 12364816 8 Type 2 diabetes mellitus
123648163 12364816 9 Diabetes mellitus
123648163 12364816 10 Hypothyroidism
123648163 12364816 11 Supplementation therapy
123648163 12364816 12 Supplementation therapy
123648163 12364816 13 Product used for unknown indication
123648163 12364816 14 Supplementation therapy
123648163 12364816 15 Supplementation therapy
123648163 12364816 16 Supplementation therapy
123648163 12364816 17 Hypersensitivity
123648163 12364816 18 Sensation of blood flow
123648163 12364816 19 Supplementation therapy

Outcome of event

Event ID CASEID OUTC COD
123648163 12364816 HO
123648163 12364816 OT

Reactions reported

Event ID CASEID DRUG REC ACT PT
123648163 12364816 Angiopathy
123648163 12364816 Apnoea
123648163 12364816 Arthralgia
123648163 12364816 Back disorder
123648163 12364816 Back pain
123648163 12364816 Bedridden
123648163 12364816 Drug ineffective
123648163 12364816 Fall
123648163 12364816 Feeling abnormal
123648163 12364816 Impaired quality of life
123648163 12364816 Joint injury
123648163 12364816 Limb discomfort
123648163 12364816 Loss of consciousness
123648163 12364816 Meniscus injury
123648163 12364816 Nightmare
123648163 12364816 Off label use
123648163 12364816 Oxygen saturation decreased
123648163 12364816 Pain
123648163 12364816 Renal disorder
123648163 12364816 Respiratory disorder
123648163 12364816 Sciatica
123648163 12364816 Sight disability
123648163 12364816 Sleep apnoea syndrome
123648163 12364816 Suicide attempt
123648163 12364816 Unevaluable event
123648163 12364816 Wheezing

Reporting Sources (this data is often not reported and may therefore be missing here)

no results found

Therapies reported

Event ID CASEID DSG DRUG SEQ START DT END DT DUR DUR COD
123648163 12364816 1 2010 0
123648163 12364816 2 20150408 0
123648163 12364816 4 2014 0
123648163 12364816 5 2016 0
123648163 12364816 6 2001 0
123648163 12364816 7 2000 0
123648163 12364816 8 2003 0
123648163 12364816 9 2014 0
123648163 12364816 10 2006 0